Tag Archives: First

Brazil Covid variant detected in New York resident for the first time, Cuomo says

Nurses talk in front of the 28 de Agosto Hospital in Manaus, Amazon State, Brazil, on January 14, 2021, amid the novel coronavirus, COVID-19, pandemic. MICHAEL DANTAS | AFP | Getty Images Gov. Andrew Cuomo said on Saturday that a more contagious Covid-19 variant, originally identified in Brazilian travelers, has now reached New York. The strain was… Read More »

World’s first satellite capacity aggregator unveils new look cloud platform neXat

neXat is a complete OSS/BSS in the cloud acting as an intermediary between teleport and hub operators and the marketplace Brussels, Belgium, 16th March 2021 – Provider of innovative satellite connectivity services SatADSL has revealed its rebranded flagship cloud services platform owing to a range of new implemented and planned features. The platform, now called… Read More »

How might pharma buddy up with Alexa? Bayer Consumer’s first interactive voice ad is food for thought

Alexa, show me the future of drug advertising? Bayer Consumer Health’s first-ever Alexa interactive ad allows consumers to buy an OTC product by talking to the Amazon device—and may foreshadow broader trends in the industry.  The U.K. ad for Bayer’s Berocca Boost, a vitamin and caffeine tablet, is running as a trial during programming streamed by Global,… Read More »

Gilead’s Veklury becomes first FDA-approved drug for treating COVID-19

Dive Brief: The Food and Drug Administration has granted a full approval to Gilead’s COVID-19 drug Veklury, making it the first medicine to win a standard clearance from the agency to treat the disease caused by the new coronavirus. The FDA authorized Veklury for emergency use in May, a declaration that’s only valid during a… Read More »

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma

PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural… Read More »